Clinical Trial Update: Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping [Phase 3]

View source ↗

Summary

Phase 3 trial update for clazosentan in adults with aneurysmal subarachnoid hemorrhage treated by surgical clipping.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Clazosentan (clazosentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Status: COMPLETED